⌘K

16:02:00·1208d

PRReleasevia Quantisnow

Ardelyx Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update

ByQuantisnow·Wall Street's wire, on your screen.

ARDX· Ardelyx Inc.

Health Care

Quantisnowquantisnow.com

Quantisnow streams SEC filings, FDA approvals, analyst ratings, insider trades, and press releases to retail investors in real time. This insight was curated and delivered from the Quantisnow live feed.

Related

Chief Patient Officer Williams Laura A exercised 31,000 shares at a strike of $0.99 and sold $490,487 worth of shares (81,898 units at $5.99) as part of a pre-agreed trading plan, decreasing direct ownership by 12% to 378,195 units (SEC Form 4)
Director Parsey Merdad was granted 26,455 shares, increasing direct ownership by 46% to 83,746 units (SEC Form 4)
Director Rodgers Richard J was granted 26,455 shares, increasing direct ownership by 6% to 439,998 units (SEC Form 4)
Director Mott David M was granted 46,737 shares, increasing direct ownership by 1% to 3,349,655 units (SEC Form 4)
Director Cadoret-Manier Onaiza was granted 26,455 shares, increasing direct ownership by 17% to 178,156 units (SEC Form 4)